English | Español
Michael McGrady | Jul 5, 2017

Policy experts weigh in on new executive order on drug pricing
Erianne Leatherman | Jul 2, 2017

Pfizer’s cardiomyopathy drug, tafamidis, on FDA fast track
Nicholas Gueguen | Jul 2, 2017

Study indicates connection between alcoholic liver disease, intestinal fungi

Nicholas Gueguen | Jul 2, 2017

Pfizer assembles findings from 13 cancers for American Society of Clinical Oncology
Erianne Leatherman | Jul 2, 2017

UC San Diego School of Medicine, Janssen Pharmaceuticals teaming up to research treatments for metabolic diseases
Cheyenne Dickerson | Jul 2, 2017

UCLA researchers say compound could aid Parkinson's patients
Cheyenne Dickerson | Jul 1, 2017

Men routinely undergo PSA testing despite recommendations, study shows
Nicholas Gueguen | Jul 1, 2017

FDA OKs Kevzara for moderate to severe rheumatoid arthritis

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

American Lung Association launches campaign for World Bronchiectasis Day
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

Coalition warns against potential impact of H.R. 1 on patient healthcare access